Arup Mukherjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Arup Mukherjee has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Suvadra Das
Basic Science and Humanities Department, University of Engineering and Management, Kolkata 700156, India
9 shared publicationsAatrayee Das
Division of Pharmaceutical and Fine Chemical Technology, Department of Chemical Technology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, West Bengal, India
6 shared publicationsSonia Kundu
Department of Food Science and Technology, Maulana Abul Kalam Azad University of Technology, NH 12, Haringhata, Nadia 741249, West Bengal, India
6 shared publicationsFarooque Abdullah
Division of Pharmaceutical and Fine Chemical Technology, Department of Chemical Technology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, West Bengal, India
5 shared publications- Partha Roy
GITAM School of Pharmacy, GITAM (Deemed to be University), Vishakhapatnam 530045, India
5 shared publications - Aalok Basu
Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
4 shared publications
Latest Publications
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A5011
Spontaneous Pneumomediastinum in a Young Man
- 1 May 2023
- Published by Oxford University Press (OUP)
- p. A5011
Spontaneous Pneumomediastinum in a Young Man
- 1 March 2022
- Published by Elsevier in Letters in Drug Design & Discovery
- Vol. 19 (3) , 192-213
Design and Study of In Silico Binding Dynamics of Certain Isoxazole Bearing Leads Against Aβ-42 and BACE-1 Loop in Protein Fibrillation
Aims: Design isoxazole bearing leads as dual inhibitors against Amyloid β and BACE-1 loop in protein fibrillation. Background: Protein fibrillation is one of the key reasons for several diseases, namely Alzheimer’s, Parkinson’s, and many others. One of the key strategies of preventing protein fibrillation is destabilizing the protein fibrils themselves or inhibiting the amyloid fibril-forming pathway in the initial stage. Introduction: Attempts have been taken to design newer leads to inhibit protein fibrillation by targeting the β-amyloidogenesis pathway in the brain. To exploit interfenestration between Amyloid β -42 protein and BACE-1 (β-site amyloid precursor protein cleaving enzyme) for amyloidogenesis, studies are undertaken to design dual inhibitors against the same. Method: In vitro binding interactions were found using docking, de novo ligand design, and MD simulation study. Results: Three compounds bearing an isoxazole heterocyclic nucleus were designed which could successfully bind to the hydrophobic raft and salt bridge residues Asp 23-Lys-26 of Amyloid β, destabilizing the growing fibril. Additionally, one of our candidate compounds exhibited force of interaction with Thr232 at the S3 pocket of BACE-1, interacted with key residue Asp228, Tyr71, and Thr72 of the β-hairpin flap and hydrogen bonding with Gly11 at loop 10s. Conclusion: Protein flexibility dynamics of the Aβ-42 protein revealed that there is a considerable conformational change of the same with or without ligand binding. The lower RMSF of the bound region and reprogramming residual contacts within the Aβ-42 protein suggested successful binding of the ligand with the protein, lowering the access for further β-β dimerization.
- 1 March 2022
- Published by Elsevier in Letters in Drug Design & Discovery
- Vol. 19 (3) , 192-213
Design and Study of In Silico Binding Dynamics of Certain Isoxazole Bearing Leads Against Aβ-42 and BACE-1 Loop in Protein Fibrillation
Aims: Design isoxazole bearing leads as dual inhibitors against Amyloid β and BACE-1 loop in protein fibrillation. Background: Protein fibrillation is one of the key reasons for several diseases, namely Alzheimer’s, Parkinson’s, and many others. One of the key strategies of preventing protein fibrillation is destabilizing the protein fibrils themselves or inhibiting the amyloid fibril-forming pathway in the initial stage. Introduction: Attempts have been taken to design newer leads to inhibit protein fibrillation by targeting the β-amyloidogenesis pathway in the brain. To exploit interfenestration between Amyloid β -42 protein and BACE-1 (β-site amyloid precursor protein cleaving enzyme) for amyloidogenesis, studies are undertaken to design dual inhibitors against the same. Method: In vitro binding interactions were found using docking, de novo ligand design, and MD simulation study. Results: Three compounds bearing an isoxazole heterocyclic nucleus were designed which could successfully bind to the hydrophobic raft and salt bridge residues Asp 23-Lys-26 of Amyloid β, destabilizing the growing fibril. Additionally, one of our candidate compounds exhibited force of interaction with Thr232 at the S3 pocket of BACE-1, interacted with key residue Asp228, Tyr71, and Thr72 of the β-hairpin flap and hydrogen bonding with Gly11 at loop 10s. Conclusion: Protein flexibility dynamics of the Aβ-42 protein revealed that there is a considerable conformational change of the same with or without ligand binding. The lower RMSF of the bound region and reprogramming residual contacts within the Aβ-42 protein suggested successful binding of the ligand with the protein, lowering the access for further β-β dimerization.
- 1 June 2021
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 180, 339-354
Newer guar gum ester/chicken feather keratin interact films for tissue engineering
- 1 June 2021
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 180, 339-354
Newer guar gum ester/chicken feather keratin interact films for tissue engineering
- Open Access
- 17 June 2020
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 1 (5) , 1142-1150
Polyphenol capping on a gold nanosurface modulates human serum albumin fibrillation
The antioxidant capacity inherent to polyphenol-capped gold nanoparticles contributed to the inhibition of human serum albumin fibrillation.
- 17 June 2020
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 1 (5) , 1142-1150
Open AccessPolyphenol capping on a gold nanosurface modulates human serum albumin fibrillation
The antioxidant capacity inherent to polyphenol-capped gold nanoparticles contributed to the inhibition of human serum albumin fibrillation.
- 1 May 2020
- Published by Elsevier in Carbohydrate Research
- Vol. 491, 107983
Guar gum cinnamate ouzo nanoparticles for bacterial contact killing in water environment
- 1 May 2020
- Published by Elsevier in Carbohydrate Research
- Vol. 491, 107983
Guar gum cinnamate ouzo nanoparticles for bacterial contact killing in water environment
- Open Access
- 31 August 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (54) , 30717-30724
Andrographolide inhibits human serum albumin fibril formations through site-specific molecular interactions
Protein misfolding and fibrillation are the fundamental traits in degenerative diseases like Alzheimer's, Parkinsonism, and diabetes mellitus. Bioactives such as flavonoids and terpenoids from plant sources are known to express protective effects against an array of diseases including diabetes, Alzheimer's and obesity. Andrographolide (AG), a labdane diterpenoid is prescribed widely in the Indian and Chinese health care systems for classical efficacy against a number of degenerative diseases. This work presents an in depth study on the effects of AG on protein fibrillating pathophysiology. Thioflavin T fluorescence spectroscopy and DLS results indicated concentration dependent inhibition of human serum albumin (HSA) fibrillation. The results were confirmed by electron microscopy studies. HSA fibril formations were markedly reduced in the presence of AG. Fluorescence studies and UV-Vis experiments confirmed further that AG molecularly interacts with HSA at site. In silico molecular docking studies revealed hydrogen bonding and hydrophobic interactions with HSA in the native state. Thus AG interacts with HSA, stabilizes the native protein structure and inhibits fibrillation. The results demonstrated that the compound possesses anti-amyloidogenic properties and can be promising against some human degenerative diseases.
- 31 August 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (54) , 30717-30724
Open AccessAndrographolide inhibits human serum albumin fibril formations through site-specific molecular interactions
Protein misfolding and fibrillation are the fundamental traits in degenerative diseases like Alzheimer's, Parkinsonism, and diabetes mellitus. Bioactives such as flavonoids and terpenoids from plant sources are known to express protective effects against an array of diseases including diabetes, Alzheimer's and obesity. Andrographolide (AG), a labdane diterpenoid is prescribed widely in the Indian and Chinese health care systems for classical efficacy against a number of degenerative diseases. This work presents an in depth study on the effects of AG on protein fibrillating pathophysiology. Thioflavin T fluorescence spectroscopy and DLS results indicated concentration dependent inhibition of human serum albumin (HSA) fibrillation. The results were confirmed by electron microscopy studies. HSA fibril formations were markedly reduced in the presence of AG. Fluorescence studies and UV-Vis experiments confirmed further that AG molecularly interacts with HSA at site. In silico molecular docking studies revealed hydrogen bonding and hydrophobic interactions with HSA in the native state. Thus AG interacts with HSA, stabilizes the native protein structure and inhibits fibrillation. The results demonstrated that the compound possesses anti-amyloidogenic properties and can be promising against some human degenerative diseases.
- 1 August 2018
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 89, 413-421
Highly monodispersed gold nanoparticles synthesis and inhibition of herpes simplex virus infections
- 1 August 2018
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 89, 413-421
Highly monodispersed gold nanoparticles synthesis and inhibition of herpes simplex virus infections
- 1 January 2018
- Published by Elsevier in Materials Today: Proceedings
- Vol. 5 (3) , 9698-9705
Smart PLGA nanoparticles loaded with Quercetin: Cellular uptake and in-vitro anticancer study
- 1 January 2018
- Published by Elsevier in Materials Today: Proceedings
- Vol. 5 (3) , 9698-9705
Smart PLGA nanoparticles loaded with Quercetin: Cellular uptake and in-vitro anticancer study
- 1 August 2017
- Published by Elsevier in Carbohydrate Polymers
- Vol. 170, 89-98
Guar gum benzoate nanoparticle reinforced gelatin films for enhanced thermal insulation, mechanical and antimicrobial properties
- 1 August 2017
- Published by Elsevier in Carbohydrate Polymers
- Vol. 170, 89-98
Guar gum benzoate nanoparticle reinforced gelatin films for enhanced thermal insulation, mechanical and antimicrobial properties